What is it about?
Cognitive function and mood disorders are fairly common among individuals with diabetes. We have shown that brain electrical activity, cardiovascular and endocrine functions can be used for selecting effective antidepressants for persons with diabetes and depression.
Featured Image
Why is it important?
Our findings show that understanding the brain activity and function is important in treating patients with type 1 diabetes and depression.
Perspectives
Selective serotonin-reuptake inhibitors (SSRIs) are widely used for treating depression. However the effectiveness of these agents among individuals are not clear. This study describes a typical case where SSRIs were ineffective (iatrogenic) and provides a neurophysiologic paradigm for selection of monoamino oxidase (MAO) inhibitor therapy.
Dr Neptune Mizrahi
Emory Neurophysiologic Institute
Read the Original
This page is a summary of: Monoamine Oxidase Inhibition in a Patient With Type 1 Diabetes and Depression, Journal of Diabetes Science and Technology, July 2016, SAGE Publications,
DOI: 10.1177/1932296816638106.
You can read the full text:
Contributors
The following have contributed to this page
